Anti-virus protein in humans may resist transmission of HIV-1 precursor from chimps

December 21, 2017, Public Library of Science
Model of SIVcpz cross species transmission to human. Credit: Zhang Z, et al. (2017)

In humans, an anti-virus protein known as APOBEC3H may defend against cross-species transmission from chimpanzees of the virus that gave rise to HIV-1. Zeli Zhang of Heinrich-Heine-Universität Düsseldorf, Germany, and colleagues present this finding in a new PLOS Pathogens study.

APOBEC3H, or A3H, is one of several anti-viral proteins known as A3s that repress replication of lentiviruses, a genus of viruses that includes HIV-1. HIV-1 originated when chimpanzee strains of simian immunodeficiency (SIVcpz) spread to humans. However, few studies have explored the effects of human A3s on SIVcpz.

In the new study, Zhang and colleagues investigated how A3 proteins in both chimpanzees and humans impact SIVcpz. They infected cells from a laboratory cell line with SIVcpz strains in the presence of different A3s. Using a novel method, the SIVcpz viruses had been genetically modified to emit light under certain conditions, enabling the researchers to quantify their infectivity in the cells.

The researchers found that a human A3 known as A3H haplotype II strongly inhibited SIVcpz. This was due to A3H's resistance to SIVcpz proteins known as Vifs, which fight back against A3s. A3H can occur in different forms, and other forms of human A3H demonstrated similar activity against SIVcpz.

Using genomic sequencing data from the Great Ape Genome Project, the research team also found that human A3H has a wider range of different possible forms than does chimpanzee A3H. Further experiments showed that Vif proteins from SIVcpz and gorilla SIV were capable of degrading chimpanzee A3H, but not A3H haplotype II.

Overall, these findings suggest that A3H may protect against transmission of SIVcpz from chimpanzees to humans. Thus, transmission of SIVcpz strains that gave rise to HIV-1 may have begun in people with unstable forms of A3H.

Explore further: HIV-like viruses in non-human primates have existed much longer than previously thought

More information: Zhang Z, Gu Q, de Manuel Montero M, Bravo IG, Marques-Bonet T, Häussinger D, et al. (2017) Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans. PLoS Pathog 13(12): e1006746. doi.org/10.1371/journal.ppat.1006746

Related Stories

HIV-like viruses in non-human primates have existed much longer than previously thought

January 24, 2013
Viruses similar to those that cause AIDS in humans were present in non-human primates in Africa at least 5 million years ago and perhaps up to 12 million years ago, according to study published January 24 in the Open Access ...

Scientists ID mutations that could allow bird flu strain to spread among humans

June 15, 2017
An international team of scientists has identified several genetic mutations that, should they arise, could potentially allow the avian influenza strain H7N9 to spread between humans. The findings are published in PLOS Pathogens.

Bat cave study sheds new light on origin of SARS virus

November 30, 2017
Genetic recombination between viral strains in bats may have produced the direct evolutionary ancestor of the strain that caused a deadly outbreak of severe acute respiratory syndrome (SARS) in humans, according to new research ...

Recommended for you

Study shows how HIV is shielded from immune attack

July 10, 2018
Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host's immune system.

Out-of-pocket costs put HIV prevention drug out of reach for many at risk

July 4, 2018
Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks—the drug's price tag, which ...

New simulation tool predicts how well HIV-prophylaxis will work

June 14, 2018
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal ...

Many at risk for HIV despite lifesaving pill

June 11, 2018
Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

Active HIV in large white blood cells may drive cognitive impairment in infected mice

June 7, 2018
Macrophages, large white blood cells that engulf and destroy potential pathogens, harbor active viral reserves that appear to play a key role in impaired learning and memory in mice infected with a rodent version of HIV. ...

HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains

June 4, 2018
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.